Prevalence and predictors of impaired fasting glucose among nigerian patients with hepatitis B virus infection

Diabetes Research and Clinical Practice

Volumn 98, Issue 2, 2012, Pages 338-345

  Iroezindu, Michael O ^a   Isiguzo, Godsent C ^b   Young, Ekenechukwu E ^a  

^a UNIVERSITY OF NIGERIA   (Nigeria)

^b UNIVERSITY OF JOS   (Nigeria)

Author keywords

Diabetes mellitus; Hepatitis B virus; Impaired fasting glucose; Predictors

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIVER ENZYME; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISORDERS OF CARBOHYDRATE METABOLISM; FAMILY HISTORY; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HEPATITIS B; HUMAN; IMPAIRED FASTING GLUCOSE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NIGERIA; RISK FACTOR; SEROPREVALENCE;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS; FASTING; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HUMANS; MALE; PREVALENCE; YOUNG ADULT;

EID: 84870549484     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.08.006     Document Type: Article

References (46)

1. Gutiérrez-Grobe Y., Ponciano-Rodríguez G., Méndez-Sánchez N. Viral hepatitis infection and insulin resistance: a review of the pathophysiological mechanisms. Salud Publica Mex 2011, 53(1):46-51.
2. Allison M.E., Wreightt T., Palmer C.R., Alexander G.J. Evidence for a link between hepatitis C virus infection and diabetes mellitus in cirrhotic population. J Hepatol 1994, 21:1135-1139.
3. Vidal J., Ferrer J.P., Esmatjes E., Salmeron J.M., González-Clemente J.M., Gomis R., et al. Diabetes mellitus in patients with liver cirrhosis. Diabetes Res Clin Pract 1994, 25(1):19-25.
4. Knobler H., Schihmanter R., Zifroni A., Fenakel G., Schattner A. Increased risk of type 2 diabetes in non-cirrhotic patients with chronic hepatitis C virus infection. Mayo Clin Proc 2000, 75(4):355-359.
5. Custro N., Carroccio A., Ganci A., Scafidi V., Campagna P., Di Prima L., et al. Glycemic homeostasis in chronic viral hepatitis and liver cirrhosis. Diabetes Metab 2001, 1:476-481.
6. Li-Ng M., Tropp S., Danoff A., Bini E.J. Association between chronic hepatitis B virus infection and diabetes among Asian Americans and Pacific Islanders. Dig Liver Dis 2007, 39(6):549-556.
7. Kumar M., Choudhury A., Manglik N., Hissar S., Rastogi A., Sakhuja P., et al. Insulin resistance in chronic hepatitis B virus infection. Am J Gastroenterol 2009, 104:76-82.
8. Alter M. Epidemiology of hepatitis B in Europe and worldwide. J Hepatol 2003, 39:64-69.
9. Gning S.B., Thiam M., Fall F., Ba-Fall K., Mbaye P.S., Fourcade L. Diabetes mellitus in sub-Saharan Africa: epidemiological aspects and management issues. Med Trop 2007, 67(6):607-611.
10. Grant B.F., Harford T.C., Dawson D.A., Chou S.P., Dufour M., Pickering R.P. Prevalence of DSM-IV alcohol abuse and dependence in United States. Alcohol Health Res World 1992, 18:243-248.
11. Friedwald W.T., Levy R.I., Friedrickson D.S. Estimation of the concentration of low density cholesterol in plasma without use of the preparatory ultracentrifugation. Clin Chem 1972, 18:499-502.
12. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15(7):539-553.
13. Alavian S.M., Hajarizadeh B., Nematizadeh F., Larijan B. Prevalence and determinants of diabetes mellitus among Iranian patients with chronic liver disease. BMC Endocr Disord 2004, 4:4. Available at: http://www.biomedcentral.com/1472-6823/4/4 [accessed 20.04.12].
14. Mavrogiannaki A., Karamanos B., Manesis E.K., Papatheodoridis G.V., Koskinas J., Archimandritis A.J. Prevalence of glucose intolerance in patients with chronic hepatitis B or C: a prospective case-control study. J Viral Hepat 2009, 16(6):430-436.
15. Mainous A.G., Diaz V.A., King D.E., Everett C.J., Player M.S. The relationship of hepatitis antibodies and elevated liver enzymes with impaired fasting glucose and undiagnosed diabetes. J Am Board Fam Med 2008, 21:497-503.
16. Huang Z.S., Huang T.S., Wu T.H., Chen M.F., Hsu C.S., Kao J.H. Asymptomatic chronic hepatitis B virus infection does not increase the risk of diabetes mellitus: a ten-year observation. J Gastroenterol Hepatol 2010, 25(8):1420-1425.
17. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2005, 28(1):37-42.
18. Rouabhia S.R., Malek R., Bounecer H., Dakaken A., Amor F.B., Sadelaoud M., et al. Prevalence of type 2 diabetes in Algerian patients with hepatitis C virus infection. World J Gastroenterol 2010, 16(27):3427-3431.
19. Caronia S., Taylor K., Pagliaro L., Carr C., Palazzo U., Petrik J., et al. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999, 30:1059-1063.
20. Kobashi-Margáin R.A., Gutiérrez-Grobe Y., Uribe M., Ponciano-Rodríguez G., Méndez-Sánchez N. Prevalence of type 2 diabetes mellitus and chronic liver disease: a retrospective study of the association of two increasingly common diseases in Mexico. Ann Hepatol 2010, 9:282-288.
21. Qureshi H., Ahsan T., Mujeeb S.A., Jawad F., Mehdi I., Ahmed W., et al. Diabetes mellitus is equally frequent in chronic HCV and HBV infection. J Pak Med Assoc 2002, 52:280-283.
22. Motala A.A., Esterhuizen T., Gouws E., Pirie F.J., Omar M.A. Diabetes and other disorders of glycemia in a rural South African community: prevalence and associated risk factors. Diabetes Care 2008, 31(9):1783-1788.
23. Dionadji M., Boy B., Mouanodji M., Batakao G. Prevalence of diabetes mellitus in rural areas in Chad. Med Trop 2010, 70(4):414-415.
24. Rguibi M., Belahsen R. Prevalence and associated risk factors of undiagnosed diabetes among adult Moroccan Sahraoui women. Public Health Nutr 2006, 9(6):722-727.
25. Amoah A.G. Undiagnosed diabetes and impaired glucose regulation in adult Ghanaians using the ADA and WHO diagnostic criteria. Acta Diabetol 2002, 39(1):7-13.
26. Baldé N.M., Diallo I., Baldé M.D., Barry I.S., Kaba L., Diallo M.M., et al. Diabetes and impaired fasting glucose in rural and urban populations in Futa Jallon (Guinea): prevalence and associated risk factors. Diabetes Metab 2007, 33(2):114-120.
27. Oyegbade O.O., Abioye-Kuteyi E.A., Kolawole B.A., Ezeoma I.T., Bello I.S. Screening for diabetes mellitus in Nigerian family practice population. SA Fam Pract 2007, 49(8):15.
28. Dahiru T., Jibo A., Hassan A.A., Mande A.T. Prevalence of diabetes in a semi-urban community in Northern Nigeria. Niger J Med 2008, 17(4):414-416.
29. Essien O.E., Peters E.J., Udoh A.E., Ekott J.U., Odigwe C.O. Prevalence and pattern of abnormal glucose tolerance in adult Nigerians with primary hypertension. Niger J Med 2007, 16(1):50-56.
30. Ogbu I.S.I., Nebor C.I. The prevalence of pre-diabetes among hypertensive patients in Enugu, South-east Nigeria. Niger Med J 2009, 50(1):14-17.
31. Zein C.O., Levy C., Basu A., Zein N.N. Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study. Am J Gastroenterol 2005, 100:48-55.
32. Giordanino C., Bugianesi E., Smedile A., Ciancio A., Abate M.L., Olivero A., et al. Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study. Am J Gastroenterol 2008, 103(10):2481-2487.
33. Wang C., Wang S., Yao W., Chang T., Chou P. Community-based study of hepatitis C virus infection and type 2 diabetes: an association affected by age and hepatitis severity status. Am J Epidemiol 2003, 158:1154-1160.
34. Papatheodoridis G.V., Chrysanthos N., Savvas S., Sevastianos V., Kafiri G., Petraki K., et al. Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis. J Viral Hepat 2006, 13(5):303-310.
35. Nannipieri M., Gonzales C., Baldi S., Posadas R., Williams K., Haffner S.M., et al. Liver enzymes, the metabolic syndrome, and incident diabetes. Diabetes Care 2005, 28:1757-1762.
36. Perry I.J., Wannamethee S.G., Shaper A.G. Prospective study of serum γ-glutamyltransferase and risk of NIDDM. Diabetes Care 1998, 21:732-737.
37. Lee D.H., Silventoinen K., Jacobs D.R., Jousilahti P., Tuomileto J. Gamma-glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women. J Clin Endocrinol Metab 2004, 89:5410-5414.
38. Nakanishi N., Suzuki K., Tatara K. Serum γ-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care 2004, 27:1427-1432.
39. Lee D.H., Ha M.H., Kim J.H., Christiani D.C., Gross M.D., Steffes M., et al. Gamma-glutamyltransferase and diabetes: a 4 year follow-up study. Diabetologia 2003, 46:359-364.
40. Ohlson L.O., Larsson B., Bjorntorp P., Eriksson H., Svardsudd K., Welin L., et al. Risk factors for type 2 (non-insulin-dependent) diabetes mellitus: thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913. Diabetologia 1988, 31:798-805.
41. Vozarova B., Stefan N., Lindsay R.S., Saremi A., Pratley R.E., Bogardus C., et al. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002, 51:1189-1895.
42. Andre P., Balkau B., Vol S., Charles M.A., Eschwege E. On behalf of the DESIR Study Group - gamma glutamyl transferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle aged men and women. Diabetes Care 2007, 30:2355-2361.
43. Schwimmer J.B., Deutsch R., Rauch J.B., Behling C., Newbury R., Lavine J.E. Obesity, insulin resistance and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 2003, 143:500-505.
44. Simó R., Lecube A., Genescà J., Esteban J.I., Hernández C. Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection. Diabetes Care 2006, 29(11):2462-2466.
45. Romeo Gomez M., Fernandez-Rodriguez C., Alonso S., Pons J.A., Lopez-Serrano P., Gutierrez M.L., et al. Sustained response in chronic hepatitis C reduces the risk of impaired fasting glucose and/or diabetes type 2. J Hepatol 2006, 44(2):548A.
46. Ryu J., Lee S., Hong S., Lee S. Association of chronic hepatitis C virus infection and diabetes mellitus in Korean patients. Kor J Int Med 2011, 16(1):18-23.